Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease

Brain Research

Volumn 1047, Issue 2, 2005, Pages 148-158

  Dalbem, André ^a   Silveira, Carine Volkweis ^a   Pedroso, Michele Franzen ^a   Breda, Ricardo Vaz ^a   Werne Baes, Cristiane Von ^a   Bartmann, Ana Paula ^a   Da Costa, Jaderson Costa ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

3 nitropropionic acid; Corticostriatal slices; Huntington's disease; Long term depression; Long term potentiation; Synaptic plasticity

Indexed keywords

3 NITROPROPIONIC ACID;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; HUNTINGTON CHOREA; LOCOMOTION; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; NEOSTRIATUM; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RODENT; SENSORIMOTOR CORTEX;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; NEURONAL PLASTICITY; NITRO COMPOUNDS; ORGAN CULTURE TECHNIQUES; PROPIONIC ACIDS; RATS; RATS, WISTAR; SYNAPSES;

EID: 20444408739     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.04.030     Document Type: Article

References (52)

1. W.C. Abraham, and M.F. Bear Metaplasticity: the plasticity of synaptic plasticity Trends Neurosci. 19 1996 126 130
2. T.A. Alston, L. Mela, and H.F. Bright 3-Nitropropionate. The toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase Proc. Natl. Acad. Sci. 74 1977 3767 3771
3. M.F. Beal Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31 1992 119 130
4. M.F. Beal, E. Brouillet, B. Jenkins, R. Henshaw, B. Rosen, and B.T. Hyman Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate J. Neurochem. 61 1993 1147 1150
5. M.F. Beal, E. Brouillet, B.G. Jenkins, R.J. Ferrante, N.W. Kowall, J.M. Miller, E. Storey, R. Srivastava, B.R. Rosen, and B.T. Hyman Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J. Neurosci. 13 1993 4181 4192
6. T.V.P. Bliss, and G.L. Colingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 1993 31 39
7. C.V. Borlongan, T.K. Koutouzis, T.S. Randall, T.B. Freeman, D.W. Cahill, and P.R. Sanberg Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats Brain. Res. Bull. 36 1995 549 556
8. P. Calabresi, R. Maj, N.B. Mercuri, and G. Bernardi Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum Neurosci. Lett. 142 1992 95 99
9. P. Calabresi, R. Maj, A. Pisani, N.B. Mercuri, and G. Bernardi Long-term synaptic depression in the striatum: physiological and pharmacological characterization J. Neurosci. 12 1992 4224 4233
10. P. Calabresi, A. Pisani, N.B. Mercuri, and G. Bernardi Long-term potentiation in the striatum is unmasked by removing the voltage-dependent blockade of NMDA receptor channel Eur. J. Neurosci. 4 1992 929 935
11. P. Calabresi, D. Centonze, P. Gubellini, A. Pisani, and G. Bernardi Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses Eur. J. Neurosci. 10 1998 3020 3023
12. P. Calabresi, D. Centonze, P. Gubellini, and G. Bernardi Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP Neuropharmacology 38 1999 323 326
13. P. Calabresi, P. Gubellini, B. Picconi, D. Centonze, A. Pisani, P. Bonsi, P. Greengard, R.A. Hipskind, E. Borrelli, and G. Bernardi Inhibition of mitochondrial complex II induces long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine J. Neurosci. 21 2001 5110 5120
14. M.A. Castro-Alamancos, and M.E. Calcagnotto Presynaptic long-term potentiation in corticothalamic synapses J. Neurosci. 19 1999 9090 9097
15. S. Charpier, and J.M. Deniau In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation Proc. Natl. Acad. Sci. 94 1997 7036 7040
16. E.J. Coan, A.J. Irving, and G.L. Collingridge Low-frequency activation of the NMDA receptor system can prevent the induction of LTP Neurosci. Lett. 105 1989 205 210
17. C.J. Coles, D.E. Edmondson, and T.P. Singer Inactivation of succinate dehydrogenase by 3-nitropropionate J. Biol. Chem. 254 1979 5161 5167
18. 2+ exchanger Exp. Neurol. 145 1997 38 45
19. S. Fujji, K. Saito, H. Miyakawa, K. Ito, and H. Kato Reversal of long-term potentiation (depotentiation) induced by tetanus stimulation of the input to CA1 neurons of guinea pig hippocampal slices Brain Res. 555 1991 112 122
20. 2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid Neuroscience 87 1998 497 507
21. M.-C. Guyot, P. Hantraye, R. Dolan, S. Palfi, M. Mazière, and E. Brouillet Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid Neuroscience 79 1997 45 56
22. B. Hassel, and U. Sonnewald Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo J. Neurochem. 65 1995 1184 1191
23. F. He, S. Zhang, F. Qian, and C. Zhang Delayed dystonia with striatal CT lucencies induced by a micotoxin (3-nitropropionic acid) Neurology 45 1995 2178 2183
24. L.L. Holland, and J.J. Wagner Primed facilitation of homosynaptic long-term depression and depotentiation in rat hippocampus J. Neurosci. 18 1998 887 894
25. C.C. Huang, and K.S. Hsu Progress in understanding the factors regulating reversibility of long-term potentiation Rev. Neurosci. 12 2001 51 68
26. Y.Y. Huang, A. Colino, D.K. Selig, and R.C. Malenka The influence of prior synaptic activity on the induction of long-term potentiation Science 255 1992 730 733
27. Y. Izaki, M. Takita, and T. Akema Compatibility of bidirectional synaptic plasticity on hippocampo-prefrontal cortex pathway in rats Neurosci. Lett. 345 2003 69 71
28. G.W. Kim, J.-C. Copin, M. Kawase, S.F. Chen, S. Sato, G.T. Gobbel, and P.H. Chan Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid J. Cereb. Blood Flow Metab. 20 2000 119 129
29. A. Kirkwood, M.G. Rioult, and M.F. Bear Experience-dependent modification of synaptic plasticity in visual cortex Nature 381 1996 526 528
30. A. Larkman, T. Hannay, K. Stratford, and J. Jack Presynaptic release probability influences the locus of long-term potentiation Nature 360 1992 70 73
31. W.T. Lee, T. Itoh, and D. Pleasure Acute and chronic alterations in calcium homeostasis in 3-nitropropionic acid-treated human NT2-N neurons Neuroscience 113 2002 699 708
32. D.M. Lovinger, E.C. Tyler, and A. Merritt Short- and long-term synaptic depression in rat neostriatum J. Neurophysiol. 70 1993 1937 1949
33. J.B. Martin, and J.F. Gusella Huntington's disease: pathogenesis and management N. Engl. J. Med. 315 1986 1267
34. U. Misgeld, M.H. Weiler, and I.J. Bak Intrinsic cholinergic excitation in the rat neostriatum: nicotinic and muscarinic receptors Exp. Brain. Res. 39 1980 401 409
35. H. Nishino, I. Fujimoto, Y. Shimano, H. Hida, M. Kumazaki, and A. Fukuda 3-nitropropionic acid produces striatum selective lesions accompanied by iNOS expression J. Chem. Neuroanat. 10 1996 209 212
36. T.J. O'Dell, and E.R. Kandel Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases Learn. Mem. 1 1994 129 139
37. S. Palfi, L. Leventhal, C.G. Goetz, P. Hantraye, B.-Z. Roitberg, J. Sramek, M. Emborg, and J.H. Kordower Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys Mov. Disord. 15 2000 524 530
38. A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, W.J. Strittmatter, and J.T. Greenamyre Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat. Neurosci. 5 2002 731 736
39. J.G. Partridge, K.C. Tang, and D.M. Lovinger Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum J. Neurophysiol. 84 2000 1422 1429
40. B.D. Philpot, J.S. Espinosa, and M.F. Bear Evidence for altered NMDA receptor function as a basis for metaplasticity in visual cortex J. Neurosci. 23 2003 5583 5588
41. B. Picconi, D. Centonze, K. Håkansson, G. Bernardi, P. Greengard, G. Fisone, M.A. Cenci, and P. Calabresi Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia Nat. Neurosci. 6 2003 501 506
42. S. Quary, N. Bizat, S. Altairac, H. Ménétrat, V. Mittoux, F. Condé, P. Hantraye, and E. Brouillet Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies Neuroscience 97 2000 521 530
43. E. Saulle, P. Gubellini, B. Picconi, D. Centonze, D. Tropepi, A. Pisani, M. Morari, M. Marti, L. Rossi, M. Papa, G. Bernardi, and P. Calabresi Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease Mol. Cell. Neurosci. 25 2004 9 20
44. R. Smith, W. Musleh, G. Akopian, G. Buckwalter, and J.P. Walsh Regional differences in the expression of corticostriatal synaptic plasticity Neuroscience 106 2001 95 101
45. J.P. Spencer, and K.P. Murphy Bi-directional changes in synaptic plasticity induced at corticostriatal synapses in vitro Exp. Brain Res. 135 2000 497 503
46. P.M. Steele, and M.D. Mauk Inhibitory control of LTP and LTD: stability of synapse strength J. Neurophysiol. 81 1999 1559 1566
47. S.J. Tabrizi, M.W. Cleeter, J. Xuereb, J.-W. Taanman, J.M. Cooper, and A.H. Shapira Biochemical abnormalities and excitotoxicity in Huntington's disease brain Ann. Neurol. 45 1999 25 32
48. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome Cell 72 1993 971 983
49. F.S. Villar, and J.P. Walsh A modulation of long-term synaptic plasticity at excitatory striatal synapses Neuroscience 90 1999 1031 1041
50. J.P.G. Vonsattel, and M. DiFiglia Huntington disease J. Neuropathol. Exp. Neurol. 57 1998 369 384
51. J.P. Walsh, and R. Dunia Synaptic activation of N-methyl-d-aspartate receptors induces short-term potentiation at excitatory synapses in the striatum of the rat Neuroscience 57 1993 241 258
52. U. Wüllner, A.B. Young, J.B. Penney, and M.F. Beal 3-Nitropropionic acid toxicity in the striatum J. Neurochem. 63 1994 1772 1781